← FDA ENFORCEMENT
D-0040-2025Class I
Staska Pharmaceuticals, Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Staska Pharmaceuticals, Inc.
Product type
Drug
Status
Terminated
Report date
2024-11-13
Distribution
Nationwide in the USA
Firm state
NE
Product quantity
4773 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Presence of Particulate Matter: Presence of glass particulates.
Product description
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
Code / lot info
Lot #SP2400058, Exp 12/31/2024
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →